Elephant in the Room: Cost of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors [Editorial]

Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Tags: Ethics and Policy, Health Services Editorial Source Type: research